Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vimpat for Seizure Prophylaxis in High-Grade Glioma
NCT01432171Phase 3Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jul 2012
- Primary completion
- Jun 2017
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in seizure comparing Vimpat Arm with Placebo Arm (2 arms). Primary endpoint: Number of Participants With Seizures at 12 months. Started Jul 2012; status: terminated.
02
Drugs
lacosamide
03
Conditions
seizure
Beyond the preview
Go deeper on NCT01432171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01432171.